OBJECTIVES: To examine whether cytomegalovirus (CMV) and herpes simplex virus type-1 (HSV-1) are associated with cognitive decline over a 4-year period and to assess whether C-reactive protein (CRP) modifies these relationships. DESIGN: Prospective cohort study over a 4-year period. SETTING: Community-dwelling elderly population. PARTICIPANTS: The sample was a subset (1,204/1,789) of participants in the Sacramento Area Latino Study on Aging (SALSA) aged 60 to 100. MEASUREMENTS: Participants were screened annually over a 4-year period for cognitive function and episodic memory. Cognitive function was assessed using the modified Mini-Mental State Examination, and episodic memory was assessed using a word list-learning test of delayed recall. Baseline serum samples were assayed for levels of immunoglobulin G antibodies to CMV and HSV-1 and for levels of CRP. RESULTS: There was a significantly higher rate of cognitive decline over the 4-year period in subjects with the highest CMV antibody levels at baseline than in individuals with the lowest levels (beta=-0.053, standard error =0.018; P=.003), after controlling for age, sex, education, income, and chronic health conditions. There was no association between HSV-1 antibody levels and cognitive decline. CRP did not modify the relationship between viral antibody levels and cognitive decline. CONCLUSION: This is the first study to show that individuals with higher levels of antibody to CMV experience a more-rapid rate of cognitive decline than those with lower levels. Understanding the mechanisms by which CMV influences cognition may aid development of intervention strategies targeting infection, viral reactivation, and immune response over the life course.
OBJECTIVES: To examine whether cytomegalovirus (CMV) and herpes simplex virus type-1 (HSV-1) are associated with cognitive decline over a 4-year period and to assess whether C-reactive protein (CRP) modifies these relationships. DESIGN: Prospective cohort study over a 4-year period. SETTING: Community-dwelling elderly population. PARTICIPANTS: The sample was a subset (1,204/1,789) of participants in the Sacramento Area Latino Study on Aging (SALSA) aged 60 to 100. MEASUREMENTS: Participants were screened annually over a 4-year period for cognitive function and episodic memory. Cognitive function was assessed using the modified Mini-Mental State Examination, and episodic memory was assessed using a word list-learning test of delayed recall. Baseline serum samples were assayed for levels of immunoglobulin G antibodies to CMV and HSV-1 and for levels of CRP. RESULTS: There was a significantly higher rate of cognitive decline over the 4-year period in subjects with the highest CMV antibody levels at baseline than in individuals with the lowest levels (beta=-0.053, standard error =0.018; P=.003), after controlling for age, sex, education, income, and chronic health conditions. There was no association between HSV-1 antibody levels and cognitive decline. CRP did not modify the relationship between viral antibody levels and cognitive decline. CONCLUSION: This is the first study to show that individuals with higher levels of antibody to CMV experience a more-rapid rate of cognitive decline than those with lower levels. Understanding the mechanisms by which CMV influences cognition may aid development of intervention strategies targeting infection, viral reactivation, and immune response over the life course.
Authors: Vishwajit L Nimgaonkar; Robert H Yolken; Tianxiu Wang; Chung-Chou H Chang; Lora McClain; Eric McDade; Beth E Snitz; Mary Ganguli Journal: Alzheimer Dis Assoc Disord Date: 2016 Jul-Sep Impact factor: 2.703
Authors: Raymond P Stowe; R Jeanne Ruiz; Christopher P Fagundes; Robin H Stowe; Min Chen; Ronald Glaser Journal: J Immunol Methods Date: 2014-05-22 Impact factor: 2.303
Authors: Mira Katan; Yeseon Park Moon; Myunghee Cho Paik; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind Journal: Neurology Date: 2013-03-26 Impact factor: 9.910
Authors: Rebeca Sara de Pablo-Bernal; Julio Cañizares; Isaac Rosado; María Isabel Galvá; Ana Isabel Alvarez-Ríos; Antonio Carrillo-Vico; Sara Ferrando-Martínez; María Ángeles Muñoz-Fernández; Mohammed Rafii-El-Idrissi Benhnia; Yolanda María Pacheco; Raquel Ramos; Manuel Leal; Ezequiel Ruiz-Mateos Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-18 Impact factor: 6.053
Authors: Clinton B Wright; Hannah Gardener; Chuanhui Dong; Mitsuhiro Yoshita; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Mitchell S V Elkind Journal: J Am Geriatr Soc Date: 2015-08 Impact factor: 5.562